Combining the epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor, ZD1839, with a selective cyclooxygenase (COX)-2 inhibitor, SC236, causes a cooperative antitumor effect in breast cancer cells derived from HER2/neu mice

By Rosato F.E.   Dicker A.   Burd R.   Miller S.   Lanza-Jacoby S.  

Journal of Surgical Research, Vol. 114, Iss. 2, 2003-10 ,pp. : 274-274

Elsevier

Access to resources Recommend Favorite

Post-ischemic stress induces Erk 1/2 activation via ligand-independent activation of the epidermal growth factor receptor (EGFR) in model intestinal epithelia

By Mammen J.M.   Song J.C.   Matthews J.B.  

Journal of Surgical Research, Vol. 114, Iss. 2, 2003-10 ,pp. : 291-291

Elsevier

Access to resources Recommend Favorite

Epidermal Growth Factor Receptor (EGFR) Expression is Associated With a Worse Prognosis in Gastric Cancer Patients Undergoing Curative Surgery

By Galizia Gennaro   Lieto Eva   Orditura Michele   Castellano Paolo   Mura Anna   Imperatore Vincenzo   Pinto Margherita   Zamboli Anna   Vita Ferdinando   Ferraraccio Francesca  

World Journal of Surgery, Vol. 31, Iss. 7, 2007-07 ,pp. : 1458-1468

Springer Publishing Company

Access to resources Recommend Favorite

Protein Kinase C Inhibits Epidermal Growth Factor Receptor Phosphorylation in Enterocytes

By Summers S.T.   Bass B.L.  

Journal of Surgical Research, Vol. 69, Iss. 1, 1997-04 ,pp. : 208-211

Academic Press

Access to resources Recommend Favorite

Chronic Treatment with Epidermal Growth Factor Induces Growth of the Rat Ventral Prostate

By Tørring N.   Jensen L. V.   Wen J. G.   Sørensen F. B.   Djurhuus J. C.   Nexø E.  

Scandinavian Journal of Urology and Nephrology, Vol. 35, Iss. 5, 2001-10 ,pp. : 339-344

Informa Healthcare

Access to resources Recommend Favorite